EBITDA

At CES 2026, Karofi is showcasing a holistic water ecosystem, moving beyond purification to integrate water management into the core of the smart home.

The fresh food packaging market is set to soar, but can it balance consumer demands for sustainability, safety, and convenience with the high costs of innovation?

A new partnership combines Edge AI processing with long-range Wi-Fi HaLow, promising to simplify and scale intelligent device deployments for enterprise.

The 2026 RAV4 will debut a radical tech upgrade with Mapbox, signaling Toyota's strategic pivot to in-house software and over-the-air updates.

With a new $195M credit facility led by JPMorgan Chase, DailyPay strengthens its position in the evolving world of employee financial wellness.

Limbach Holdings appoints M&A and operations expert Terry Dugan to its board, a strategic move aimed at accelerating growth in mission-critical markets.

Dash cam leader Nextbase is turning millions of drivers into data collectors with its new InSight platform, promising to reshape our cities and roads.

The finalized deal reshapes Louisiana's banking map, adding nine branches and creating a regional giant. What does this mean for customers and competition?

IP Atlas Media launches IPAC, a new model for valuing intellectual property, aiming to redefine economic strength in a world driven by intangible assets.

Latin America's largest investment bank completes its takeover of M.Y. Safra Bank, gaining a coveted US banking license to serve global clients.

Family safety app Life360 acquires ad-tech firm Nativo, using its vast location data to build an ad empire. Can it balance profit with user privacy?

KIOXIA's new BG7 SSDs use breakthrough BiCS FLASH Gen 8 and CBA tech to deliver major speed and power efficiency gains for the next generation of PCs.

A new health initiative aims to fight chronic disease with personalized nutrition. But can data from your body truly fix a broken food system?

At CES 2026, Ubicept's new toolkit promises to let AI see clearly in the dark and at high speed, ushering in a new era for robotics and autonomous cars.

Lucid crushed its 2025 production goals with a huge Q4 surge, but a widening gap between cars built and sold raises serious questions about demand.

BridGene Biosciences adds Nobel winner Dr. Bruce Beutler to its board, gaining immense credibility for its mission to create drugs for intractable diseases.

Founder Chuck Cohn pours millions more into his ed-tech firm, a bold move that signals deep confidence despite a slumping stock and cautious analysts.

Fintech firm Movemint's rebrand signals a major shift for banks, focusing on embedded finance and personalized experiences to drive measurable growth.

With a hot obesity pipeline and a key neurology asset, Nxera Pharma's J.P. Morgan talk is a crucial test of its plan for global leadership.

With stunning clinical data for its miv-cel therapy, Kyverna is set to outline a new era for autoimmune treatment at the J.P. Morgan conference.